Skip to content

Science1 publisher3 min readPublished

UCSF's 20-person pilot shows a larger trial of cutting ultra-processed food for depression is workable

UCSF researchers found 20 people with depression improved on three symptom scales after cutting ultra-processed food by more than 85%. Participants knew which diet they were eating, so the pilot mainly shows that a bigger trial can be run and does not yet show that the food caused the improvement.

The Scientist · Science desk

Illustration accompanying UCSF's 20-person pilot shows a larger trial of cutting ultra-processed food for depression is workable

What happened

  • All had a high BMI and at least one metabolic disorder, such as hypertension, diabetes or elevated LDL cholesterol.
  • Anxiety scores also improved, by an amount the release describes as modest.
  • Enrollment for a larger phase 2 trial is expected to begin in 2028.

Compiled by The ScientistSomething wrong?How this is made

Why it matters

  • capability People buying their own groceries managed a cut of more than 85%. A phase 2 trial needs exactly this evidence: that participants will stick to the diet without the study supplying meals.
  • constraint Participants knew which diet they were on, so the pilot cannot separate an effect of the food from the effect of expecting to feel better. The larger trial has to deal with that before anyone can say the diet treats depression.
  • constraint The finding applies to depressed adults with a high BMI and metabolic disease. Whether people with depression and normal metabolic health would respond is still untested.

The design is the strongest thing in this study. Researchers split the participants into two groups. One kept its usual diet for four weeks while the other switched to a diet low in ultra-processed food, and then the groups traded places [5]. That put each person in the study for eight weeks [1], and each was compared against themselves. This removes the simplest alternative explanation, that the people who ate better happened to start out less depressed. The authors believe it is the first study to compare depression symptoms in the same participants before and after they moved off their usual ultra-processed diet [6].

The weakness is that participants knew what they were eating. They chose and bought their own food, with guidance from the research team [7]. Someone who knows she is in the healthier-diet phase may report feeling better for reasons unrelated to emulsifiers. A crossover with no blinding cannot separate that from an effect of the food.

The improvements were moderate to large across three depression measures [3], and anxiety scores improved modestly [4]. The release does not give the scores or their confidence intervals. With 20 participants [16], those intervals are likely to be wide. Andrew Krystal, the senior author, put feasibility first. The pilot "successfully established the viability of carrying out this research in a larger-scale trial," he said [8].

The pilot makes a stronger case on that question. A larger trial depends on people changing what they eat without the study supplying their meals. These participants cut their intake of ultra-processed food by more than 85% while buying their own groceries [2][7]. Nyasha Chagwedera, the corresponding author, explained why that is hard. "Reducing the amount of ultra-processed food in our diet can be challenging, because it's highly palatable, cheap, and convenient," she said [9].

The sample was narrow. Participants averaged 44 years old and 70% were female [10]. Fourteen of the 20 also had anxiety [11], or 70% [2]. Every participant had a high BMI and at least one metabolic disorder, such as hypertension, diabetes or elevated LDL cholesterol [12]. The result concerns depression in people with metabolic disease. Depressed people with normal metabolic health were outside the study.

Chagwedera's proposed explanation is what she called a "leaky, out-of-balance gut," in which ultra-processed foods may damage the gut's protective lining [13]. "This gut damage can create low-grade, chronic inflammation throughout the body that either directly causes depression or makes people more vulnerable to it," she said [14]. The release offers this as one possible explanation for the link [13].

The team plans to test the effect in a larger group, with phase 2 enrollment expected to begin in 2028 [15]. The pilot appeared in JAMA Psychiatry on Sept. 23, 2026 [1], so the gap between publication and enrollment is about two years [3].

What to watch

  • Whether the phase 2 protocol adds a comparison condition that accounts for participants knowing which diet they are eating.
  • Whether the full JAMA Psychiatry paper's scale scores and confidence intervals hold up the 'moderate to large' description at a sample of 20.
  • Whether phase 2 measures gut-lining or inflammation markers to test Chagwedera's leaky-gut explanation directly.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories